O	O	0	12	Differential	Differential	B-NP	JJ	O	2	NMOD	O
O	O	13	20	effects	effect	I-NP	NNS	O	0	ROOT	O
O	O	21	23	of	of	B-PP	IN	O	2	NMOD	O
T22	B-Entity	24	31	protein	protein	B-NP	NN	B-protein	7	NMOD	B-protein
T22	I-Entity	32	38	kinase	kinase	I-NP	NN	I-protein	7	NMOD	I-protein
T22	I-Entity	39	40	C	C	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	41	51	inhibitors	inhibitor	I-NP	NNS	O	3	PMOD	O
O	O	52	54	on	on	B-PP	IN	O	2	NMOD	O
T1	B-Protein	55	66	fibronectin	fibronectin	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	66	67	-	-	O	HYPH	O	9	P	O
O	O	67	74	induced	induce	B-NP	VBN	O	16	NMOD	O
T2	B-Protein	75	86	interleukin	interleukin	I-NP	NN	B-protein	16	NMOD	B-protein
T2	I-Protein	86	87	-	-	B-NP	HYPH	O	16	NMOD	O
T2	I-Protein	87	91	beta	beta	I-NP	SYM	O	16	NMOD	O
O	O	92	96	gene	gene	I-NP	NN	O	16	NMOD	O
O	O	97	110	transcription	transcription	I-NP	NN	O	21	NMOD	O
O	O	110	111	,	,	O	,	O	21	P	O
O	O	112	119	protein	protein	B-NP	NN	O	19	NMOD	O
O	O	120	129	synthesis	synthesis	I-NP	NN	O	21	NMOD	O
O	O	130	133	and	and	O	CC	O	21	NMOD	O
O	O	134	143	secretion	secretion	B-NP	NN	O	8	PMOD	O
O	O	144	146	in	in	B-PP	IN	O	21	NMOD	O
O	O	147	152	human	human	B-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	153	162	monocytic	monocytic	I-NP	JJ	I-cell_type	25	NMOD	I-cell_type
O	O	163	168	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	168	169	.	.	O	.	O	2	P	O

O	O	171	176	Human	Human	B-NP	JJ	B-cell_type	3	NMOD	B-cell_type
O	O	177	186	monocytic	monocytic	I-NP	JJ	I-cell_type	3	NMOD	I-cell_type
O	O	187	192	cells	cell	I-NP	NNS	I-cell_type	4	SUB	I-cell_type
O	O	193	200	express	express	B-VP	VBP	O	0	ROOT	O
T3	B-Protein	201	212	interleukin	interleukin	B-NP	NN	B-protein	7	NMOD	B-protein
T3	I-Protein	212	213	-	-	B-NP	HYPH	O	7	NMOD	O
T3	I-Protein	213	218	1beta	1beta	I-NP	NN	O	4	OBJ	O
O	O	219	220	(	(	O	(	O	12	DEP	O
T4	B-Protein	220	222	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Protein	222	223	-	-	B-NP	HYPH	I-protein	11	P	I-protein
T4	I-Protein	223	228	1beta	1beta	I-NP	NN	I-protein	12	DEP	I-protein
O	O	228	229	)	)	O	)	O	7	NMOD	O
O	O	230	234	when	when	B-ADVP	WRB	O	4	VMOD	O
O	O	235	245	stimulated	stimulate	B-VP	VBN	O	13	SBAR	O
O	O	246	250	with	with	B-PP	IN	O	14	VMOD	O
O	O	251	254	the	the	B-NP	DT	O	19	NMOD	O
O	O	255	268	extracellular	extracellular	I-NP	JJ	B-protein	19	NMOD	B-protein
O	O	269	275	matrix	matrix	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	276	288	glycoprotein	glycoprotein	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	288	289	,	,	O	,	O	13	P	O
T5	B-Protein	290	301	fibronectin	fibronectin	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	302	303	(	(	O	(	O	24	DEP	O
T6	B-Protein	303	305	FN	FN	B-NP	NN	B-protein	24	DEP	B-protein
O	O	305	306	)	)	O	)	O	21	NMOD	O
O	O	306	307	.	.	O	.	O	21	P	O

T23	B-Entity	308	315	Protein	Protein	B-NP	NN	B-protein	3	NMOD	B-protein
T23	I-Entity	316	322	kinase	kinase	I-NP	NN	I-protein	3	NMOD	I-protein
T23	I-Entity	323	324	C	C	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	325	326	(	(	O	(	O	6	DEP	O
T24	B-Entity	326	329	PKC	PKC	B-NP	NN	B-protein	6	DEP	B-protein
O	O	329	330	)	)	O	)	O	3	NMOD	O
O	O	331	341	activation	activation	B-NP	NN	O	8	SUB	O
O	O	342	344	is	be	B-VP	VBZ	O	35	VMOD	O
O	O	345	355	considered	consider	I-VP	VBN	O	8	VC	O
O	O	356	365	important	important	B-ADJP	JJ	O	9	VMOD	O
O	O	366	369	for	for	B-PP	IN	O	10	AMOD	O
O	O	370	374	this	this	B-NP	DT	O	13	NMOD	O
O	O	375	382	process	process	I-NP	NN	O	11	PMOD	O
O	O	382	383	;	;	O	:	O	35	P	O
O	O	384	391	however	however	B-ADVP	RB	O	35	VMOD	O
O	O	391	392	,	,	O	,	O	35	P	O
O	O	393	396	the	the	B-NP	DT	O	19	NMOD	O
O	O	397	406	metabolic	metabolic	I-NP	JJ	O	19	NMOD	O
O	O	407	412	steps	step	I-NP	NNS	O	35	SUB	O
O	O	413	415	at	at	B-PP	IN	O	19	NMOD	O
O	O	416	421	which	which	B-NP	WDT	O	20	PMOD	O
T25	B-Entity	422	425	PKC	PKC	B-NP	NN	B-protein	23	SUB	B-protein
O	O	426	430	acts	act	B-VP	VBZ	O	20	SBAR	O
O	O	431	435	upon	upon	B-PP	IN	O	23	VMOD	O
O	O	436	438	to	to	B-VP	TO	O	26	VMOD	O
O	O	439	446	mediate	mediate	I-VP	VB	O	24	SBAR	O
O	O	447	450	the	the	B-NP	DT	O	28	NMOD	O
T7	B-Protein	451	453	FN	FN	I-NP	NN	B-protein	34	NMOD	B-protein
O	O	453	454	-	-	B-VP	HYPH	O	28	P	O
O	O	454	461	induced	induce	B-NP	VBN	O	28	AMOD	O
T8	B-Protein	462	464	IL	IL	I-NP	NN	B-protein	34	NMOD	B-protein
T8	I-Protein	464	465	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T8	I-Protein	465	470	1beta	1beta	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	471	479	response	response	I-NP	NN	O	26	OBJ	O
O	O	480	486	remain	remain	B-VP	VBP	O	0	ROOT	O
O	O	487	494	unclear	unclear	B-ADJP	JJ	O	35	PRD	O
O	O	494	495	.	.	O	.	O	35	P	O

O	O	496	498	We	We	B-NP	PRP	O	2	SUB	O
O	O	499	508	performed	perform	B-VP	VBD	O	0	ROOT	O
O	O	509	511	an	an	B-NP	DT	O	4	NMOD	O
O	O	512	520	analysis	analysis	I-NP	NN	O	2	OBJ	O
O	O	521	523	of	of	B-PP	IN	O	4	NMOD	O
O	O	524	527	the	the	B-NP	DT	O	7	NMOD	O
O	O	528	538	mechanisms	mechanism	I-NP	NNS	O	17	NMOD	O
O	O	539	541	by	by	B-PP	IN	O	7	NMOD	O
O	O	542	547	which	which	B-NP	WDT	O	8	PMOD	O
O	O	548	551	two	two	B-NP	CD	O	12	NMOD	O
T26	B-Entity	552	555	PKC	PKC	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	556	566	inhibitors	inhibitor	I-NP	NNS	O	8	PMOD	O
O	O	566	567	,	,	O	,	O	17	P	O
O	O	568	578	Calphostin	Calphostin	B-NP	NN	O	15	NMOD	O
O	O	579	580	C	C	I-NP	NN	O	17	NMOD	O
O	O	581	584	and	and	I-NP	CC	O	17	NMOD	O
O	O	585	598	Staurosporine	Staurosporine	I-NP	NN	O	5	PMOD	O
O	O	598	599	,	,	O	,	O	2	P	O
O	O	600	607	prevent	prevent	B-VP	VBP	O	2	VMOD	O
O	O	608	611	the	the	B-NP	DT	O	27	NMOD	O
T9	B-Protein	612	614	FN	FN	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	614	615	-	-	B-VP	HYPH	O	27	NMOD	O
O	O	615	622	induced	induce	B-NP	VBN	O	27	NMOD	O
T10	B-Protein	623	625	IL	IL	I-NP	NN	B-protein	27	NMOD	B-protein
T10	I-Protein	625	626	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T10	I-Protein	626	631	1beta	1beta	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	632	640	response	response	I-NP	NN	O	19	OBJ	O
O	O	640	641	.	.	O	.	O	2	P	O

O	O	642	646	Both	Both	B-NP	DT	O	2	NMOD	O
O	O	647	657	inhibitors	inhibitor	I-NP	NNS	O	3	SUB	O
O	O	658	665	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	666	669	the	the	B-NP	DT	O	5	NMOD	O
O	O	670	679	secretion	secretion	I-NP	NN	O	3	OBJ	O
O	O	680	682	of	of	B-PP	IN	O	5	NMOD	O
T11	B-Protein	683	685	IL	IL	B-NP	NN	B-protein	10	NMOD	B-protein
T11	I-Protein	685	686	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T11	I-Protein	686	691	1beta	1beta	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	692	699	protein	protein	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	700	704	into	into	B-PP	IN	O	5	NMOD	O
O	O	705	708	the	the	B-NP	DT	O	13	NMOD	O
O	O	709	714	media	medium	I-NP	NNS	O	11	PMOD	O
O	O	715	717	of	of	B-PP	IN	O	13	NMOD	O
O	O	718	728	peripheral	peripheral	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	729	734	blood	blood	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	735	746	mononuclear	mononuclear	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	747	752	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	753	760	exposed	expose	B-VP	VBN	O	18	NMOD	O
O	O	761	763	to	to	B-PP	TO	O	19	VMOD	O
T12	B-Protein	764	766	FN	FN	B-NP	NN	B-protein	20	PMOD	B-protein
O	O	766	767	.	.	O	.	O	3	P	O

O	O	768	787	Immunoprecipitation	Immunoprecipitation	B-NP	NN	O	2	NMOD	O
O	O	788	796	analysis	analysis	I-NP	NN	O	3	SUB	O
O	O	797	805	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	806	810	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	811	816	under	under	B-PP	IN	O	11	VMOD	O
O	O	817	822	these	these	B-NP	DT	O	7	NMOD	O
O	O	823	836	circumstances	circumstance	I-NP	NNS	O	5	PMOD	O
O	O	836	837	,	,	O	,	O	11	P	O
O	O	838	848	Calphostin	Calphostin	B-NP	NN	O	10	NMOD	O
O	O	849	850	C	C	I-NP	NN	O	11	SUB	O
O	O	851	860	inhibited	inhibit	B-VP	VBD	O	4	SBAR	O
O	O	861	864	the	the	B-NP	DT	O	13	NMOD	O
O	O	865	875	production	production	I-NP	NN	O	11	OBJ	O
O	O	876	878	of	of	B-PP	IN	O	13	NMOD	O
T13	B-Protein	879	881	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T13	I-Protein	881	882	-	-	I-NP	HYPH	I-protein	18	NMOD	I-protein
T13	I-Protein	882	887	1beta	1beta	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	888	895	protein	protein	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	895	896	,	,	O	,	O	11	P	O
O	O	897	904	whereas	whereas	O	IN	O	11	VMOD	O
O	O	905	918	Staurosporine	Staurosporine	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	919	926	allowed	allow	B-VP	VBD	I-protein	24	NMOD	I-protein
O	O	927	934	protein	protein	B-NP	NN	I-protein	24	NMOD	I-protein
O	O	935	945	production	production	I-NP	NN	O	27	SUB	O
O	O	945	946	,	,	O	,	O	27	P	O
O	O	947	950	but	but	O	CC	O	27	VMOD	O
O	O	951	960	inhibited	inhibit	B-VP	VBD	O	20	SBAR	O
O	O	961	964	its	its	B-NP	PRP$	O	29	NMOD	O
O	O	965	974	secretion	secretion	I-NP	NN	O	27	OBJ	O
O	O	974	975	.	.	O	.	O	3	P	O

O	O	976	978	To	To	B-VP	TO	O	2	VMOD	O
O	O	979	988	determine	determine	I-VP	VB	O	11	VMOD	O
O	O	989	992	the	the	B-NP	DT	O	4	NMOD	O
O	O	993	1003	mechanisms	mechanism	I-NP	NNS	O	2	OBJ	O
O	O	1004	1015	responsible	responsible	B-ADJP	JJ	O	4	NMOD	O
O	O	1016	1019	for	for	B-PP	IN	O	5	AMOD	O
O	O	1020	1025	these	these	B-NP	DT	O	8	NMOD	O
O	O	1026	1037	differences	difference	I-NP	NNS	O	6	PMOD	O
O	O	1037	1038	,	,	O	,	O	11	P	O
O	O	1039	1041	we	we	B-NP	PRP	O	11	SUB	O
O	O	1042	1048	turned	turn	B-VP	VBD	O	0	ROOT	O
O	O	1049	1051	to	to	B-PP	TO	O	11	VMOD	O
O	O	1052	1057	human	human	B-NP	JJ	B-cell_line	16	NMOD	B-cell_line
O	O	1058	1062	U937	U937	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	1063	1075	promonocytic	promonocytic	I-NP	JJ	I-cell_line	16	NMOD	I-cell_line
O	O	1076	1081	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	1081	1082	.	.	O	.	O	11	P	O

O	O	1083	1087	U937	U937	B-NP	NN	B-cell_line	2	NMOD	B-cell_line
O	O	1088	1093	cells	cell	I-NP	NNS	I-cell_line	20	SUB	I-cell_line
O	O	1094	1105	transfected	transfecte	B-VP	VBN	O	2	NMOD	O
O	O	1106	1110	with	with	B-PP	IN	O	3	VMOD	O
O	O	1111	1114	the	the	B-NP	DT	O	13	NMOD	O
O	O	1115	1120	human	human	I-NP	JJ	B-DNA	13	NMOD	B-DNA
O	O	1121	1125	full	full	I-NP	JJ	I-DNA	13	NMOD	I-DNA
O	O	1125	1126	-	-	I-NP	HYPH	I-DNA	13	NMOD	I-DNA
O	O	1126	1132	length	length	I-NP	NN	I-DNA	13	NMOD	I-DNA
T14	B-Protein	1133	1135	IL	IL	I-NP	NN	I-DNA	13	NMOD	I-DNA
T14	I-Protein	1135	1136	-	-	B-NP	HYPH	I-DNA	13	NMOD	I-DNA
T14	I-Protein	1136	1141	1beta	1beta	I-NP	NN	I-DNA	13	NMOD	I-DNA
T27	B-Entity	1142	1150	promoter	promoter	I-NP	NN	I-DNA	4	PMOD	I-DNA
O	O	1151	1160	connected	connect	B-VP	VBN	O	13	NMOD	O
O	O	1161	1163	to	to	B-PP	TO	O	14	VMOD	O
O	O	1164	1165	a	a	B-NP	DT	O	19	NMOD	O
T28	B-Entity	1166	1176	luciferase	luciferase	I-NP	NN	B-DNA	19	NMOD	B-DNA
T28	I-Entity	1177	1185	reporter	reporter	I-NP	NN	I-DNA	19	NMOD	I-DNA
T28	I-Entity	1186	1190	gene	gene	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	1191	1195	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1196	1205	submitted	submit	I-VP	VBN	O	20	VC	O
O	O	1206	1208	to	to	B-PP	TO	O	21	VMOD	O
O	O	1209	1222	transcription	transcription	B-NP	NN	O	24	NMOD	O
O	O	1223	1229	assays	assay	I-NP	NNS	O	22	PMOD	O
O	O	1229	1230	,	,	O	,	O	35	P	O
O	O	1231	1239	Northern	Northern	B-NP	NN	O	27	NMOD	O
O	O	1240	1248	blotting	blotting	I-NP	NN	O	35	NMOD	O
O	O	1248	1249	,	,	O	,	O	35	P	O
O	O	1250	1253	and	and	O	CC	O	35	NMOD	O
O	O	1254	1257	DNA	DNA	B-NP	NN	O	35	NMOD	O
O	O	1258	1273	electrophoresis	electrophoresis	I-NP	NN	O	35	NMOD	O
O	O	1274	1282	mobility	mobility	I-NP	NN	O	35	NMOD	O
O	O	1283	1286	gel	gel	I-NP	NN	O	35	NMOD	O
O	O	1287	1292	shift	shift	I-NP	NN	O	35	NMOD	O
O	O	1293	1299	assays	assay	I-NP	NNS	O	20	VMOD	O
O	O	1299	1300	.	.	O	.	O	20	P	O

O	O	1301	1306	These	These	B-NP	DT	O	2	NMOD	O
O	O	1307	1314	studies	study	I-NP	NNS	O	3	SUB	O
O	O	1315	1323	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	1324	1328	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1329	1339	Calphostin	Calphostin	B-NP	NN	O	6	NMOD	O
O	O	1340	1341	C	C	I-NP	NN	O	7	SUB	O
O	O	1342	1351	inhibited	inhibit	B-VP	VBD	O	4	SBAR	O
O	O	1352	1355	the	the	B-NP	DT	O	10	NMOD	O
O	O	1356	1363	nuclear	nuclear	I-NP	JJ	O	10	NMOD	O
O	O	1364	1377	translocation	translocation	I-NP	NN	O	7	OBJ	O
O	O	1378	1380	of	of	B-PP	IN	O	10	NMOD	O
O	O	1381	1384	the	the	B-NP	DT	O	16	NMOD	O
T29	B-Entity	1385	1398	transcription	transcription	I-NP	NN	B-protein	16	NMOD	B-protein
T29	I-Entity	1399	1405	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T29	I-Entity	1406	1415	activator	activator	I-NP	NN	I-protein	16	NMOD	I-protein
T29	I-Entity	1416	1423	protein	protein	I-NP	NN	I-protein	11	PMOD	I-protein
T29	I-Entity	1423	1424	-	-	B-NP	HYPH	O	18	P	O
T29	I-Entity	1424	1425	1	1	I-NP	CD	O	16	NMOD	O
O	O	1426	1427	(	(	O	(	O	23	DEP	O
T30	B-Entity	1427	1429	AP	AP	B-NP	NN	B-protein	21	NMOD	B-protein
T30	I-Entity	1429	1430	-	-	B-NP	HYPH	I-protein	23	DEP	I-protein
T30	I-Entity	1430	1431	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	1431	1432	)	)	O	)	O	16	NMOD	O
O	O	1433	1438	which	which	B-NP	WDT	O	16	NMOD	O
O	O	1439	1441	is	be	B-VP	VBZ	O	24	SBAR	O
O	O	1442	1452	considered	consider	I-VP	VBN	O	25	VC	O
O	O	1453	1462	necessary	necessary	B-ADJP	JJ	O	26	VMOD	O
O	O	1463	1466	for	for	B-PP	IN	O	27	AMOD	O
T15	B-Protein	1467	1469	FN	FN	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	1470	1479	induction	induction	I-NP	NN	O	28	PMOD	O
O	O	1480	1482	of	of	B-PP	IN	O	30	NMOD	O
T16	B-Protein	1483	1485	IL	IL	B-NP	NN	B-DNA	36	NMOD	B-DNA
T16	I-Protein	1485	1486	-	-	B-NP	HYPH	I-DNA	36	NMOD	I-DNA
T16	I-Protein	1486	1491	1beta	1beta	I-NP	NN	I-DNA	36	NMOD	I-DNA
O	O	1492	1496	gene	gene	I-NP	NN	I-DNA	36	NMOD	I-DNA
O	O	1497	1510	transcription	transcription	I-NP	NN	O	31	PMOD	O
O	O	1510	1511	,	,	O	,	O	3	P	O
O	O	1512	1515	and	and	O	CC	O	3	VMOD	O
O	O	1516	1525	prevented	prevent	B-VP	VBD	O	3	VMOD	O
O	O	1526	1529	the	the	B-NP	DT	O	41	NMOD	O
O	O	1530	1543	transcription	transcription	I-NP	NN	O	39	OBJ	O
O	O	1544	1546	of	of	B-PP	IN	O	41	NMOD	O
O	O	1547	1550	the	the	B-NP	DT	O	47	NMOD	O
T17	B-Protein	1551	1553	IL	IL	I-NP	NN	B-DNA	47	NMOD	B-DNA
T17	I-Protein	1553	1554	-	-	B-NP	HYPH	I-DNA	47	NMOD	I-DNA
T17	I-Protein	1554	1559	1beta	1beta	I-NP	NN	I-DNA	47	NMOD	I-DNA
O	O	1560	1564	gene	gene	I-NP	NN	I-DNA	42	PMOD	I-DNA
O	O	1564	1565	.	.	O	.	O	3	P	O

O	O	1566	1568	In	In	B-PP	IN	O	6	VMOD	O
O	O	1569	1577	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1577	1578	,	,	O	,	O	6	P	O
O	O	1579	1592	Staurosporine	Staurosporine	B-NP	NN	O	6	SUB	O
O	O	1593	1598	alone	alone	B-ADVP	RB	O	4	NMOD	O
O	O	1599	1606	induced	induce	B-VP	VBD	O	0	ROOT	O
T31	B-Entity	1607	1609	AP	AP	B-NP	NN	B-protein	10	NMOD	B-protein
T31	I-Entity	1609	1610	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T31	I-Entity	1610	1611	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	1612	1625	translocation	translocation	I-NP	NN	O	12	NMOD	O
O	O	1626	1629	and	and	I-NP	CC	O	12	NMOD	O
O	O	1630	1641	stimulation	stimulation	I-NP	NN	O	6	OBJ	O
O	O	1642	1644	of	of	B-PP	IN	O	12	NMOD	O
O	O	1645	1648	the	the	B-NP	DT	O	15	NMOD	O
O	O	1649	1653	gene	gene	I-NP	NN	O	13	PMOD	O
O	O	1653	1654	.	.	O	.	O	6	P	O

O	O	1655	1662	Overall	Overall	B-ADVP	RB	O	5	VMOD	O
O	O	1662	1663	,	,	O	,	O	5	P	O
O	O	1664	1667	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	1668	1672	data	datum	I-NP	NNS	O	5	SUB	O
O	O	1673	1681	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1682	1686	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1687	1697	Calphostin	Calphostin	B-NP	NN	O	8	NMOD	O
O	O	1698	1699	C	C	I-NP	NN	O	9	SUB	O
O	O	1700	1708	prevents	prevent	B-VP	VBZ	O	6	SBAR	O
O	O	1709	1712	the	the	B-NP	DT	O	11	NMOD	O
O	O	1713	1726	transcription	transcription	I-NP	NN	O	9	OBJ	O
O	O	1727	1729	of	of	B-PP	IN	O	11	NMOD	O
O	O	1730	1733	the	the	B-NP	DT	O	17	NMOD	O
T18	B-Protein	1734	1736	IL	IL	I-NP	NN	B-DNA	17	NMOD	B-DNA
T18	I-Protein	1736	1737	-	-	B-NP	HYPH	I-DNA	17	NMOD	I-DNA
T18	I-Protein	1737	1742	1beta	1beta	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	1743	1747	gene	gene	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	1748	1755	thereby	thereby	B-VP	RB	O	19	VMOD	O
O	O	1756	1766	inhibiting	inhibit	I-VP	VBG	O	9	VMOD	O
O	O	1767	1774	protein	protein	B-NP	NN	O	21	NMOD	O
O	O	1775	1784	synthesis	synthesis	I-NP	NN	O	19	OBJ	O
O	O	1784	1785	.	.	O	.	O	5	P	O

O	O	1786	1791	Based	Base	B-PP	VBN	O	13	VMOD	O
O	O	1792	1794	on	on	B-PP	IN	O	1	PMOD	O
O	O	1795	1798	the	the	B-NP	DT	O	5	NMOD	O
O	O	1799	1803	high	high	I-NP	JJ	O	5	NMOD	O
O	O	1804	1815	specificity	specificity	I-NP	NN	O	2	PMOD	O
O	O	1816	1818	of	of	B-PP	IN	O	5	NMOD	O
O	O	1819	1823	this	this	B-NP	DT	O	8	NMOD	O
O	O	1824	1832	compound	compound	I-NP	NN	O	6	PMOD	O
O	O	1833	1836	for	for	B-PP	IN	O	5	NMOD	O
T32	B-Entity	1837	1840	PKC	PKC	B-NP	NN	B-protein	9	PMOD	B-protein
O	O	1840	1841	,	,	O	,	O	13	P	O
O	O	1842	1844	we	we	B-NP	PRP	O	13	SUB	O
O	O	1845	1853	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	1854	1858	that	that	B-SBAR	IN	O	13	VMOD	O
T33	B-Entity	1859	1862	PKC	PKC	B-NP	NN	B-protein	16	SUB	B-protein
O	O	1863	1865	is	be	B-VP	VBZ	O	14	SBAR	O
O	O	1866	1875	necessary	necessary	B-ADJP	JJ	O	16	PRD	O
O	O	1876	1879	for	for	B-PP	IN	O	17	AMOD	O
T19	B-Protein	1880	1882	FN	FN	B-NP	NN	B-protein	21	AMOD	B-protein
O	O	1882	1883	-	-	O	HYPH	O	19	P	O
O	O	1883	1890	induced	induce	B-NP	VBN	O	26	NMOD	O
T20	B-Protein	1891	1893	IL	IL	I-NP	NN	B-protein	26	NMOD	B-protein
T20	I-Protein	1893	1894	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T20	I-Protein	1894	1899	1beta	1beta	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	1900	1907	protein	protein	I-NP	NN	O	26	NMOD	O
O	O	1908	1918	production	production	I-NP	NN	O	18	PMOD	O
O	O	1918	1919	.	.	O	.	O	13	P	O

O	O	1920	1922	In	In	B-PP	IN	O	5	VMOD	O
O	O	1923	1931	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1931	1932	,	,	O	,	O	5	P	O
O	O	1933	1946	Staurosporine	Staurosporine	B-NP	NN	O	5	SUB	O
O	O	1947	1956	prevented	prevent	B-VP	VBD	O	0	ROOT	O
O	O	1957	1966	secretion	secretion	B-NP	NN	O	5	OBJ	O
O	O	1967	1969	of	of	B-PP	IN	O	6	NMOD	O
T21	B-Protein	1970	1972	IL	IL	B-NP	NN	B-protein	10	NMOD	B-protein
T21	I-Protein	1972	1973	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T21	I-Protein	1973	1978	1beta	1beta	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	1979	1981	by	by	B-PP	IN	O	5	VMOD	O
O	O	1982	1989	unknown	unknown	B-NP	JJ	O	13	NMOD	O
O	O	1990	2000	mechanisms	mechanism	I-NP	NNS	O	11	PMOD	O
O	O	2000	2001	.	.	O	.	O	5	P	O
